FDA Releases Guidance On Submissions For Ai/Ml-Enabled Devices - Life Sciences, Biotechnology & Nanotechnology

On April 3, 2023, the Food and Drug Administration (FDA) published in the Federal Register an announcement of availability for the draft guidance, Marketing Submission Recommendation...

Related Keywords

,Device Software ,Drug Administration ,Device Software Function ,Key Takeaways ,Predetermined Change Control ,Federal Register ,Marketing Submission Recommendations ,Predetermined Change Control Plan ,Machine Learning ,Enabled Device Software ,Predetermined Change Control Protocols ,Medical Device ,Proposed Regulatory Framework ,Based Software ,Discussion Paper ,Medical Device Action Plan ,Reauthorization Act ,Software Function ,Machine Learning Enabled ,Change Control ,Modification Protocol ,Impact Assessment ,Premarket Approval ,Deciding When ,Existing Device ,Devices Subject ,Decision Making Process ,Quality System ,Mondaq ,Fda Releases Guidance On Submissions For Ai Ml Enabled Devices ,Food ,Drugs ,Healthcare ,Life Sciences ,Iotechnology Amp Nanotechnology ,Technology ,New Technology ,